Acetylsalicylic Acid (Aspirin, BAYE4465)
Acetylsalicylic Acid (Aspirin, BAYE4465) is a pharmaceutical drug with 16 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
16 of 16 finished
0.0%
0 ended early
0
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold
Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg
Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EU
Clinical Trials (16)
Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Symptomatic Treatment of Sore Throat Associated With a Common Cold
Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg
Effectiveness of Low Dose Aspirin in Decreasing the Chance Getting Stomach and Intestine Cancer
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Study to Develop a Prediction Model to Understand the Effect of Low-dose Aspirin on Cancer That Develops in the Colon and/or the Rectum, Diseases That Affects the Heart or Blood Vessels and Safety Outcomes in European Countries. The Study is Also Called PEACOS Model EU
Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum
Evaluate Analgesic Efficacy of Fast Release Aspirin
Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN)
Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
Naproxen Sodium/ASA Platelet Study
Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type Headache
Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Throat Associated With a Common Cold
Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold
Pharmacokinetic Study Comparing Aspirin and Aspirin Granules
Placebo and Active Controlled Study to Compare the Antipyretic Efficacy of Aspirin® in Patients With Acute Febrile Upper Respiratory Tract Infections Suspected to be of Viral Origin
Placebo and Active Controlled, Double Dummy Study to Prove Efficacy of Aspirin in Treatment of Acute Low Back Pain
All 16 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 16